In the past month, Tonix Pharmaceuticals Holding Corp. has unveiled three separate partnerships to advance its efforts towards a vaccine for novel coronavirus, including a collaboration focused on precision medicine in both preventing and treating COVID-19.
On 16 July, the biotech announced that it will work with researchers at Columbia University to investigate the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?